Varenicline and bupropion sustained-release combination therapy for smoking cessation.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Nicotine & Tobacco Research

• Publication date

  2009-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1093/ntr/ntn031PMID 19246427
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Nicotine replacement therapy for smoking cessation.

  2008cited by this paper
• Effects of abstinence from tobacco: valid symptoms and time course.

  2007cited by this paper
• Randomized comparison of a nicotine inhaler and bupropion for smoking cessation and relapse prevention.

  2007cited by this paper
• Metabolism and disposition of varenicline, a selective alpha4beta2 acetylcholine receptor partial agonist, in vivo and in vitro.

  2006cited by this paper
• METABOLISM AND DISPOSITION OF VARENICLINE, A SELECTIVE α4β2 ACETYLCHOLINE RECEPTOR PARTIAL AGONIST, IN VIVO AND IN VITRO

  2006cited by this paper
• Varenicline, an α4β2 Nicotinic Acetylcholine Receptor Partial Agonist, vs Sustained-Release Bupropion and Placebo for Smoking Cessation: A Randomized Controlled Trial

  2006cited by this paper
• Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial.

  2006cited by this paper
• Effect of maintenance therapy with varenicline on smoking cessation: a randomized controlled trial.

  2006cited by this paper
• Efficacy of Varenicline, an 42 Nicotinic Acetylcholine Receptor Partial Agonist, vs Placebo or Sustained-Release Bupropion for Smoking Cessation A Randomized Controlled Trial

  2006cited by this paper
• Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: a randomized controlled trial.

  2006cited by this paper
• Varenicline: an alpha4beta2 nicotinic receptor partial agonist for smoking cessation.

  2005cited by this paper
• Varenicline: An α4β2 Nicotinic Receptor Partial Agonist for Smoking Cessation

  2005cited by this paper
• Nicotine replacement therapy for smoking cessation.

  2004cited by this paper
• Nicotine Activation of α4* Receptors: Sufficient for Reward, Tolerance, and Sensitization

  2004cited by this paper
• Enantioselective Effects of Hydroxy Metabolites of Bupropion on Behavior and on Function of Monoamine Transporters and Nicotinic Receptors

  2004cited by this paper
• Measures of abstinence in clinical trials: issues and recommendations.

  2003cited by this paper
• Bupropion sustained release for treatment of tobacco dependence.

  2003cited by this paper
• The need for dissemination of evidence-based results from research on nicotine and tobacco.

  2003cited by this paper
• Biochemical verification of tobacco use and cessation.

  2002cited by this paper
• Smokers deprived of cigarettes for 72 h: effect of nicotine patches on craving and withdrawal

  2002cited by this paper
• A three-outcome design for phase II clinical trials.

  2001cited by this paper
• Bupropion is a nicotinic antagonist.

  2000cited by this paper
• Nicotine nasal spray with nicotine patch for smoking cessation: randomised trial with six year follow up

  1999cited by this paper
• A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation.

  1999cited by this paper
• Papers

  1999cited by this paper
• A comparison of sustained-release bupropion and placebo for smoking cessation.

  1997cited by this paper
• Combined use of nicotine patch and gum in smoking cessation: a placebo-controlled clinical trial.

  1995cited by this paper
• The Contemplation Ladder: validation of a measure of readiness to consider smoking cessation.

  1991cited by this paper
• The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire.

  1991cited by this paper
• The CES-D Scale: A Self-Report Depression Scale for Research in the General Population — Source link

  year unknowncited by this paper

• Nicotine receptor partial agonists for smoking cessation

  2023cites this paper
• Conduite du sevrage tabagique

  2023cites this paper
• Nicotine receptor partial agonists for smoking cessation

  2023cites this paper
• An Open-label Pilot Study of NicoBloc as a Novel Smoking Cessation Intervention

  2023cites this paper
• Active versus sham transcranial direct current stimulation (tDCS) as an adjunct to varenicline treatment for smoking cessation: Study protocol for a double-blind single dummy randomized controlled trial

  2022cites this paper
• Initiating Pharmacologic Treatment in Tobacco-Dependent Adults.

  2022cites this paper
• Cue restricted smoking increases quit rates with varenicline

  2021cites this paper
• Oxidative Stress and Neuroinflammation as a Pivot in Drug Abuse. A Focus on the Therapeutic Potential of Antioxidant and Anti-Inflammatory Agents and Biomolecules

  2020cites this paper
• Smoking cessation services in the Eastern Mediterranean Region: highlights and findings from the WHO Report on the Global Tobacco Epidemic 2019.

  2020cites this paper
• Nicotine Dependence

  2020cites this paper
• EPIDEMIOLOGIA PALENIA TYTONIU I METODY EFEKTYWNIE WSPIERAJĄCE WALKĘ Z UZALEŻNIENIEM OD NIKOTYNY

  2019cites this paper
• The influence of cessation aid on predicting weight change during smoking cessation

  2019cites this paper
• Updated Cardiovascular Prevention Guideline of the Brazilian Society of Cardiology - 2019

  2019cites this paper
• Evaluation of Serum Levels of Inflammation, Fibrinolysis and Oxidative Stress Markers in Coronary Artery Disease Prediction: A Cross-Sectional Study

  2019cites this paper
• Persistent attenuation of nicotine self‐administration in rats by co‐administration of chronic nicotine infusion with the dopamine D1 receptor antagonist SCH‐23390 or the serotonin 5‐HT2C agonist lorcaserin

  2019cites this paper
• Review of the role of cigarette smoking in diabetic foot

  2018cites this paper
• Adherence to Pharmacological Smoking Cessation Interventions: A Literature Review and Synthesis of Correlates and Barriers

  2018cites this paper
• Recommendations of SEPAR Treatment of Smoking in Smokers With Chronic Obstructive Pulmonary Disease

  2018cites this paper
• Tobacco Dependence Treatment: Pharmacist’s Role

  2018cites this paper
• Cancer Survivor Health Needs for Women.

  2018cites this paper
• Smoking Cessation and Cardiac Rehabilitation: A Priority!

  2018cites this paper
• The use of varenicline to treat nicotine dependence among patients with cancer

  2017cites this paper
• Step Care treatment for smoking cessation

  2017cites this paper
• The influence of sleep quality on smoking cessation in socioeconomically disadvantaged adults.

  2017cites this paper
• Nicotine receptor partial agonists for smoking cessation.

  2016cites this paper
• Combination bupropion SR and varenicline for smoking cessation: a systematic review

  2016influential citation
• New Pharmacological Agents to Aid Smoking Cessation and Tobacco Harm Reduction: What Has Been Investigated, and What Is in the Pipeline?

  2016cites this paper
• Varenicline for Smoking Cessation: a Review

  2016cites this paper
• Zonisamide Reduces Withdrawal Symptoms But Does Not Enhance Varenicline-Induced Smoking Cessation.

  2016cites this paper
• Bupropion and naltrexone for smoking cessation: A double‐blind randomized placebo‐controlled clinical trial

  2016cites this paper
• The American Journal of Drug and Alcohol Abuse Encompassing All Addictive Disorders

  2016influential citation
• A Critical Review of Repurposing Apomorphine for Smoking Cessation

  2015cites this paper
• Using parallel latent growth curve models to better understand co-morbidity in two randomized clinical trials: Smoking with co-morbid ADHD and co-morbid SUD

  2015cites this paper
• Pharmacotherapy to Quit: Beyond the Guidelines

  2015cites this paper
• Bupropion-varenicline interactions and nicotine self-administration behavior in rats.

  2015cites this paper
• The effect of switching pharmacological intervention during extinction on nicotine-evoked conditioned responding in rats

  2015cites this paper
• An Official American Thoracic Society Research Statement: Current Understanding and Future Research Needs in Tobacco Control and Treatment.

  2015cites this paper
• Emerging drugs for the treatment of tobacco dependence: 2014 update

  2014cites this paper
• Addiction science: Uncovering neurobiological complexity.

  2014cites this paper
• Conduite du sevrage tabagique

  2014cites this paper
• Larval Zebrafish Model for FDA-Approved Drug Repositioning for Tobacco Dependence Treatment

  2014cites this paper
• Combination Varenicline/Bupropion Treatment in an Adaptive Smoking Cessation Paradigm

  2014cites this paper
• Eficacia y seguridad del uso de medicamentos para la cesación de la adicción al tabaco: revisión de guías de práctica clínica

  2014cites this paper
• Combination treatment with varenicline and bupropion in an adaptive smoking cessation paradigm.

  2014cites this paper
• A randomized trial of concurrent smoking-cessation and substance use disorder treatment in stimulant-dependent smokers.

  2014cites this paper
• Pharmacotherapy for smoking cessation: pharmacological principles and clinical practice

  2014cites this paper
• [Efficacy and safety of medication use for the cessation of tobacco addiction: A review of Clinical Practice Guidelines].

  2014cites this paper
• Smoking cessation in men and women.

  2014cites this paper
• Combination varenicline and bupropion SR for tobacco-dependence treatment in cigarette smokers: a randomized trial.

  2014cites this paper
• Tobacco use and cessation for cancer survivors: An overview for clinicians

  2014cites this paper
• Clinical phenotypes related to smoking cessation.

  2013cites this paper
• Does combination pharmacological intervention for smoking cessation prevent post-cessation weight gain? A systemic review.

  2013cites this paper
• An internet survey of use, opinions and preferences for smoking cessation medications: nicotine, varenicline, and bupropion.

  2013cites this paper
• Clinical Strategies to Enhance the Efficacy of Nicotine Replacement Therapy for Smoking Cessation: A Review of the Literature

  2013cites this paper
• Smoking cessation in patients with respiratory disease: existing treatments and future directions.

  2013cites this paper
• Treatment of Smoking in Smokers With Chronic Obstructive Pulmonary Disease

  2013cites this paper
• Smoking Cessation: Update

  2013cites this paper
• Current and Emerging Pharmacotherapeutic Options for Smoking Cessation

  2013cites this paper
• I Diretriz Brasileira de Prevencao Cardiovascular

  2013cites this paper
• Tratamiento del tabaquismo en fumadores con enfermedad pulmonar obstructiva crónica

  2013cites this paper
• Outcomes from a patient-centered residential treatment plan for tobacco dependence.

  2013cites this paper
• Smoking cessation interventions for smokers with current or past depression.

  2013cites this paper
• Effectiveness of coadministration of varenicline, bupropion, and serotonin reuptake inhibitors in a smoking cessation program in the real-life setting.

  2013cites this paper
• Treatment of smoking in smokers with chronic obstructive pulmonary disease. Sociedad Española de Neumología y Cirugía Torácica (SEPAR).

  2013cites this paper
• Clinical Strategies to Enhance the Efficacy of Nicotine Replacement Therapy for Smoking Cessation: A Review of the Literature Matthew J. CarpenterBianca F. JardinJessica L. Burris • Amanda R. MathewRobert A. SchnollNancy A. Rigotti •

  2013cites this paper
• [National consensus of diagnosis and treatment of non-small cell lung cancer].

  2013cites this paper
• Centre for Smoking Cessation and Training NCSCT Briefing : 7 Cost-effectiveness of pharmacotherapy for smoking cessation

  2012cites this paper
• Effectiveness of Anti-Smoking Interventions after General Medical Examination in a Health Promotion Center-Based Smoking Cessation Settings: Experience of a Single Clinic in Korea

  2012cites this paper
• Design considerations for a study to evaluate the impact of smoking cessation treatment on stimulant use outcomes in stimulant-dependent individuals.

  2012cites this paper
• Smoking Prevention and Cessation in the Africa and Middle East Region : A Consensus Draft Guideline for Healthcare Providers – Full Text

  2012cites this paper
• Cessação do tabagismo em idosos

  2012cites this paper
• [Guidelines for COPD prevention, diagnosis and treatment in Argentina].

  2012cites this paper
• 7 Nicotine Dependence

  2012cites this paper
• Nicotine receptor partial agonists for smoking cessation

  2012cites this paper
• Pharmacological Interventions for the Treatment of Smokeless Tobacco Use

  2012cites this paper
• Strategies to help a smoker who is struggling to quit.

  2012cites this paper
• Use of the Patient Health Questionnaire-2 to predict suicidal ideations in patients taking varenicline.

  2012cites this paper
• Cessação do tabagismo em idosos

  2012cites this paper
• Perioperative smoking cessation.

  2012cites this paper
• This material is the copyright of the original publisher. Unauthorised copying and distribution is prohibited. Pharmacological Interventions for the Treatment of Smokeless Tobacco Use

  2012cites this paper
• RECOMENDACIONES PARA LA PREVENCIóN, DIAGNóSTICO y TRATAMIENTO DE LA EPOC EN LA ARGENTINA

  2012cites this paper
• Interventions to Address Chronic Disease and HIV: Strategies to Promote Smoking Cessation Among HIV-infected Individuals

  2012cites this paper
• Aspectos neuropsicológicos del craving por la nicotina Neuropsychological aspects of nicotine craving

  2011cites this paper
• Pharmacotherapy for smoking cessation: present and future.

  2011cites this paper
• Cost-effectiveness of pharmacotherapy for smoking cessation

  2011cites this paper
• A Retrospective Comparison of Varenicline Monotherapy Versus the Combination of Varenicline and Bupropion or Bupropion and Nicotine Patches in a VA Tobacco Cessation Clinic

  2011cites this paper
• Nicotine vaccines.

  2011cites this paper
• Pharmacotherapy for Smoking Cessation

  2011cites this paper
• [Neuropsychological aspects of nicotine craving].

  2011cites this paper
• Nicotine receptor partial agonists for smoking cessation.

  2011cites this paper
• Residential treatment compared with outpatient treatment for tobacco use and dependence.

  2011cites this paper
• Subjective sleep disturbance during a smoking cessation program: associations with relapse.

  2011cites this paper
• An approach to the patient with substance use and abuse.

  2010cites this paper
• Combination Pharmacotherapy for Stopping Smoking

  2010cites this paper
• Varenicline in smoking cessation

  2010cites this paper
• Smoking as a Chronic Disease

  2010cites this paper
• Advances in smoking cessation.

  2010cites this paper
• A Randomized Clinical Trial of St. John's Wort for Smoking Cessation

  2010cites this paper
• Varenicline for smoking cessation: efficacy, safety, and treatment recommendations

  2010cites this paper
• Pharmacological Aids to Promote Smoking Cessation

  2010cites this paper